Cytosorbents (CTSO) Proxy Filing summary

Executive summary

• Annual meeting scheduled for June 12, 2025, to be held virtually for shareholder participation.

• Shareholders are encouraged to review proxy materials and annual report before voting.

Voting matters and shareholder proposals

• Election of five director nominees: Phillip P. Chan, Michael G. Bator, Edward R. Jones, Alan D. Sobel, and Jiny Kim.

• Advisory vote on executive compensation for named executive officers.

• Ratification of WithumSmith + Brown, PC as independent auditors for fiscal year ending December 31, 2025.

• Provision to address other business that may arise during the meeting or any adjournments.

Board of directors and corporate governance

• Board recommends voting in favor of all director nominees and proposals.